Skip to main content

Year: 2022

Upwork to Report Third Quarter 2022 Financial Results on October 26, 2022

SAN FRANCISCO, Oct. 04, 2022 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with independent talent, as measured by gross services volume (“GSV”), today announced that it will report its financial results for the third quarter of 2022 on Wednesday, October 26, 2022 after market close. The company will host a Q&A conference call to discuss these results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. A live webcast of the call will be available on the Upwork Investor Relations website at investors.upwork.com. An audio replay of the conference call will be available for one week following the call and will be archived via webcast on the Upwork Investor Relations website at investors.upwork.com for approximately one year. About UpworkUpwork is the...

Continue reading

Journey Medical Corporation to Participate in Upcoming October 2022 Investor Conferences

SCOTTSDALE, Ariz., Oct. 04, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will participate in two upcoming investor conferences. Details of the events are as follows:Roth Inaugural Healthcare Opportunities Conference: The company will present on Thursday, October 6, 2022, at 12:15 p.m. ET and will participate in one-on-one meetings during the conference, which will be held at The Yale Club in New York City. LD Micro Main Event XV Conference: The company will present on Tuesday, October 25, 2022, at 3:00 p.m. PT and will also participate in one-on-one...

Continue reading

Tenaya Therapeutics to Present Preclinical Data on Its Novel Engineered AAV Capsids for Cardiac Gene Delivery at the ESGCT 29th Annual Congress

SOUTH SAN FRANCISCO, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced today that it will present new preclinical data on its novel AAV capsids for cardiac gene delivery at the 29th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), October 11 – 14, 2022 in Edinburgh, Scotland. Data being presented will detail Tenaya’s progress in developing novel adeno-associtaed viral (AAV) capsids designed to deliver cardiac gene therapy with enhanced specificity and expression compared to current AAV vectors, with the hope of optimizing gene therapy safey, dosing and efficacy. Details of the presentation...

Continue reading

DAXOR CORPORATION TO EXHIBIT AND PRESENT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’22 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)

The Premier Event For The Cardiovascular Industry’s Leading Network of Executives and Clinicians – Sharing Best Practices, Guidance and Resources to Dramatically Improve Their Business and Patient-Care Outcomes Oak Ridge, TN, Oct. 04, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will be exhibiting for the first time at the MedAxiom CV Transforum Fall’22 Conference being held at the JW Marriott in Austin, TX from October 6-8, 2022. The CV Transforum conference unites cardiovascular thought leaders from across the country to transform cardiovascular care together with leading industry innovators. Daxor recently announced in July that it has entered an industry partnership with MedAxiom, an American College of Cardiology company, to...

Continue reading

Good Gaming Inc. Announces Its Reveal Event For The Water Bear PFP, The First of Ten Species That Make Up The Genesis Collections And Their Cross Platform “Buddyverse”

Kennett Square, PA, Oct. 04, 2022 (GLOBE NEWSWIRE) — Good Gaming, Inc. (OTCQB: GMER) (the “Company”), an innovative brand creating unique interactive entertainment experiences across the gaming segment since 2008, is excited to announce it is holding a reveal event today for its Water Bear PFP in anticipation of its MicroBuddies™ PFP Project. As previously announced, the first of the ten highly anticipated mints of The Genesis Collections, the Water Bear PFP, is scheduled to be released today, October 4th, 2022. The Genesis Collections are Good Gaming’s Web3 digital collectibles extension of the Microbuddies IP targeted at Web3 natives. The project will be available on the decentralized, open-source Ethereum blockchain. The Genesis Collections will also feature cross-platform functionality with the MicroBuddies™...

Continue reading

Water Ways Receives Recurring Order From a Blueberry Grower in Mexico

Blueberry Smart Irrigation Blueberry Smart IrrigationNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) (“Water Ways” or the “Company“), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, announces that it has received an additional order to deliver smart irrigation equipment to a blueberry grower in Mexico (see press release dated May 4, 2022). The total value of the order is C$180,000. Water Ways expects to recognize revenue and deliver the order in Q4 of 2022. Ohad Haber, Chairman and Chief Executive Officer, commented: “Our business in Mexico is increasing and we expect additional orders still this...

Continue reading

Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer

SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the appointment of Andrew L. Concoff M.D. FACR, CAQSM as Chief Innovation Officer. In this role, Dr. Concoff will lead the company’s rheumatoid arthritis medical initiatives, including the AVISE® RADR platform (Rheumatoid Arthritis Drug Response). Dr. Concoff will be a key principal in strategy, business development, portfolio management, pipeline prioritization, and formation of new business ventures, as well as the advancement of innovative access partnerships with payors and governments globally. “Exagen is deeply committed to rheumatology where we believe there are significant unmet needs in the diagnosis, prognosis, and monitoring of autoimmune diseases, that our tests can uniquely address,”...

Continue reading

TC Energy to build its first solar energy project in Canada

Future rendering of TC Energy solar farm at Saddlebrook, near Aldersyde, Alta. Future rendering of TC Energy solar farm at Saddlebrook, near Aldersyde, Alta.Future rendering of TC Energy solar farm at Saddlebrook, near Aldersyde, Alta. CALGARY, Alberta, Oct. 04, 2022 (GLOBE NEWSWIRE) — News Release — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy) will begin pre-construction activities of the Saddlebrook Solar Project located near Aldersyde, Alberta. TC Energy is investing $146 million to build its first Canadian solar power project. It has the capacity to generate 81 megawatts, enough energy to power 20,000 homes annually. The initial construction includes installing solar panels on TC Energy property in the local industrial park. “This is the first utility-scale solar project to be fully developed and delivered by...

Continue reading

Jushi Holdings Inc. Strengthens Board of Directors and Senior Leadership Team

Jushi Holdings Inc. has appointed Bill Wafford to its Board of Directors Bill Wafford, Seasoned Finance Executive and Former JCPenney CFO, to Serve as Independent Director and Chair of the Audit CommitteeBill Wafford, Seasoned Finance Executive and Former JCPenney CFO, to Serve as Independent Director and Chair of the Audit Committee Tobi Lebowitz Promoted to Chief Legal Officer and Corporate Secretary BOCA RATON, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, today announced that it has appointed Bill Wafford to its Board of Directors, effective immediately. In addition to his appointment as Independent Director, Mr. Wafford will serve as Chair of the Audit Committee. Mr. Wafford is a highly skilled...

Continue reading

CoreCard Corporation Announces New Board Member

NORCROSS, Ga., Oct. 04, 2022 (GLOBE NEWSWIRE) — CoreCard Corporation (NYSE: CCRD) announced the addition of a new board member, Kathryn Petralia, to serve as an independent Director of the Company. Ms. Petralia is the Co-Founder of Keep Financial, a fintech compensation platform that helps employers and employees stay together longer and happier. Prior to starting Keep, Kathryn Co-Founded Kabbage, a financial services, technology and data platform for small businesses that was acquired by American Express in 2020. Prior to Kabbage, Kathryn spent nearly 15 years with fintech and ecommerce startups. After graduating from Furman University with an English degree, Kathryn pursued her interest in technology to launch a number of successful startups. She also served as Vice President of Strategy for Revolution Money, which was acquired...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.